Balance Sheet: Assets
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Geographic Areas
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Analysis of Revenues
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., consolidated balance sheet: assets
US$ in thousands
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The analysis of the annual financial data reveals several notable trends and developments across the reported periods.
- Cash and cash equivalents
- The cash and cash equivalents balance increased from approximately 2.19 billion USD in 2020 to a peak of around 3.11 billion USD in 2022. However, this amount subsequently declined over the next two years, reaching about 2.49 billion USD by 2024. This reflects a reduction in liquid cash reserves after a period of accumulation.
- Marketable securities
- Marketable securities show two sets of figures, possibly indicating separate classifications. The first series grew substantially from about 1.39 billion USD in 2020 to a high of roughly 8.11 billion USD in 2023, before decreasing to around 6.52 billion USD in 2024. Conversely, the second series increased from approximately 3.14 billion USD in 2020 to 6.84 billion USD in 2021, fluctuated thereafter, and ultimately rose to 8.90 billion USD in 2024. Overall, marketable securities experienced significant growth, reflecting increased investment in short-term or liquid financial instruments.
- Accounts receivable, net
- Accounts receivable exhibited a generally upward trend, rising from 4.11 billion USD in 2020 to 6.21 billion USD in 2024. The balance peaked in 2021 at 6.04 billion USD, dipped in 2022, and then steadily increased over the following years. These movements may indicate fluctuations in credit sales or collection efficiency.
- Inventories
- Inventory levels consistently increased from approximately 1.92 billion USD in 2020 to 3.09 billion USD in 2024, indicating a buildup of stock over time. This steady rise could suggest preparations for higher sales volumes or possible challenges in inventory turnover.
- Prepaid expenses and other current assets
- Prepaid expenses and other current assets nearly doubled from 161 million USD in 2020 to a peak of 411 million USD in 2022, followed by a decline to 349 million USD by 2024. This pattern suggests changes in advance payments or other short-term assets that are time-sensitive.
- Current assets
- Current assets increased notably from around 9.78 billion USD in 2020 to a maximum of 19.48 billion USD in 2023, then slightly decreased to 18.66 billion USD in 2024. The growth largely tracks increases in marketable securities and accounts receivable, contributing to the rise in liquidity and short-term resources.
- Property, plant, and equipment, net
- The net value of property, plant, and equipment advanced steadily each year from 3.22 billion USD in 2020 to about 4.60 billion USD in 2024. This consistent growth indicates ongoing capital investments and potential capacity expansion.
- Intangible assets, net
- Starting with no reported balance in 2020, intangible assets appeared in 2021 at 6.7 million USD and then rose sharply to 1.15 billion USD by 2024. This significant increase suggests acquisitions, licensing agreements, or capitalization of intellectual property.
- Deferred tax assets
- Deferred tax assets gradually increased from 859 million USD in 2020 to over 3.31 billion USD in 2024, reflecting accumulation of tax-related benefits to be realized in the future, which may be linked to profitability and tax planning strategies.
- Other noncurrent assets
- Other noncurrent assets showed a marked rise from 168 million USD in 2020 to over 1.14 billion USD in 2024, indicating diversification or increases in long-term investments not classified elsewhere.
- Noncurrent assets
- Noncurrent assets rose significantly from 7.38 billion USD in 2020 to approximately 19.10 billion USD in 2024. The increase is driven by growth in property, plant and equipment, intangible assets, deferred tax assets, and other long-term assets, pointing to expansion and strengthened asset base.
- Total assets
- Total assets nearly doubled over the period, from 17.16 billion USD in 2020 to 37.76 billion USD in 2024, highlighting robust asset growth. This expansion reflects the combined effects of increased current and noncurrent assets, indicative of company growth and investment over the period.